Nektar Therapeutics
NKTR
#5687
Rank
HK$9.01 B
Marketcap
HK$442.94
Share price
-1.37%
Change (1 day)
272.04%
Change (1 year)

Nektar Therapeutics (NKTR) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : HK$1.68 Billion

According to Nektar Therapeutics 's latest financial reports the company's total liabilities are HK$1.68 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Nektar Therapeutics - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31HK$1.88 B-9.5%
2023-12-31HK$2.08 B-22.39%
2022-12-31HK$2.68 B-21.25%
2021-12-31HK$3.41 B-4.6%
2020-12-31HK$3.57 B-19.69%
2019-12-31HK$4.45 B31.49%
2018-12-31HK$3.38 B2.98%
2017-12-31HK$3.28 B-11.76%
2016-12-31HK$3.72 B-2.28%
2015-12-31HK$3.81 B21.36%
2014-12-31HK$3.14 B-22.7%
2013-12-31HK$4.06 B16.39%
2012-12-31HK$3.49 B10.06%
2011-12-31HK$3.17 B-5.26%
2010-12-31HK$3.35 B-8.67%
2009-12-31HK$3.66 B28.18%
2008-12-31HK$2.86 B-28.12%
2007-12-31HK$3.98 B-5.39%
2006-12-31HK$4.20 B2.08%
2005-12-31HK$4.12 B91.12%
2004-12-31HK$2.15 B-38.51%
2003-12-31HK$3.50 B12.5%
2002-12-31HK$3.11 B0.75%
2001-12-31HK$3.09 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Amgen
AMGN
HK$626.83 B 37,133.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$900.17 B 53,370.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$604.38 B 35,800.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Richardson Electronics
RELL
HK$0.31 B-81.18%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$533.12 B 31,567.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
Baxter
BAX
HK$107.84 B 6,305.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
HK$4.64 B 175.63%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Johnson & Johnson
JNJ
HK$883.85 B 52,400.91%๐Ÿ‡บ๐Ÿ‡ธ USA